Fecal Bacteriotherapy for Recurrent Clostridium difficile Infection: What’s Old Is New Again?
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
In recent years, effective management of recurrent Clostridium difficile infection (CDI) has emerged as an important issue for those clinicians who treat patients with CDI. In addition to antibiotic-based therapies, including alternating use, chaser, and tapering protocols, interest has increased in the potential utility of a variety of nonantibiotic forms of adjunctive therapy. Among these alternative forms of treatment, the concept of transferring extracts of a stool from donors to patients with CDI has been met with great interest among researchers, clinicians, and patients alike. Fecal bacteriotherapy, or so-called fecal microbiota transplantation, for therapy of CDI is a procedure that dates back to the 1950s. Recently, however, a variety of studies have garnered attention in the lay press, in addition to the standard scientific-reporting community. Although no well-controlled trials have been published as yet and the details of the procedures used have varied widely between institutions, the available evidence suggests that for selected patients, fecal bacteriotherapy appears to be generally safe and effective. Concerns about true efficacy and the theoretical potential for infectious complications have prevented widespread adoption of this concept as standard therapy, but its use in academic and community practices is on the rise.
- McKenna M. Swapping germs: Should fecal transplants become routine for debilitating diarrhea? Scientific American. 2011. http://www.scientificamerican.com/article.cfm?id=swapping-germs. Accessed 26 Nov 2012.
- El-Matary, Simpson R, Ricketts-Burns N. Fecal microbiota transplantation: are we opening a can of worms? Gastroenterology. 2012;143:e19. CrossRef
- Qin J, Li R, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59–65. CrossRef
- Costello EK, Stagaman K, et al. The application of ecological theory toward an understanding of the human microbiome. Science. 2012;336:1255–62. CrossRef
- Mueller K, Ash C, Pennisi E, Smith O. Introduction: the gut microbiota. Science. 2012;336:1245. CrossRef
- Nicholson JK, Holmes H, et al. Host-gut microbiota metabolic interactions. Science. 2012;336:1262–67. CrossRef
- Hooper LV, Littman DR, MacPherson AJ, et al. Interactions between the microbiota and the immune system. Science. 2012;336:1268–73. CrossRef
- Chang JY, Antonopoulos DA, Kalra A, et al. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile associated diarrhea. J Infect Dis. 2008;197:435–8. CrossRef
- Shahinas D, Silverman M, Sittler T, et al. Toward an understanding of changes in diversity associated with fecal microbiome transplantation based on 16S rRNA gene deep sequencing. MBio. 2012;3:e00338–12. CrossRef
- Suwantarat N, Bobak DA. Current status of nonantibiotic and adjunct therapies for Clostridium difficile infection. Curr Infect Dis Rep. 2011;13:21–7. CrossRef
- Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis. 2011;53:994–1002. CrossRef
- Guo B, Harstall C, Louie T, et al. Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease. Aliment Pharmacol Ther. 2012;35:865–75. CrossRef
- Kelly CR, de Leon L, Jasutkar N. Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results. J Clin Gastroenterol. 2012;46:145–9. CrossRef
- Mattila E, Uusitalo-Sappala R, Lehtola L, et al. Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. Gastroenterology. 2012;142:490–6. CrossRef
- Brandt LJ, Aroniadis OC, Mellow M, et al. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012;107:1079–87. CrossRef
- Eiseman B, Silen W, Bascom GS, Kauvar AJ. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery. 1958;44:854–9.
- Khoruts A, Dicksved J, Jahnsson JK, Sadowsky MJ. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile associated infection. J Clin Gastroenterol. 2010;44:354–60.
- Grehan MJ, Borody TJ, Leis SM, et al. Durable alteration of the colonic microbiota by the administration of donor fecal flora. J Clin Gastroenterol. 2010;44:551–61. CrossRef
- Hamilton MJ, Weingarden AR, Sadowsky MJ, Khoruts A. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012;107:761–7. CrossRef
- Zipursky JS, Sidorsky TI, Freedman CA, et al. Patient attitudes toward the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection. Clin Infect Dis. 2012;55:1652–8. CrossRef
- Brandt LJ. Fecal microbiota transplantation: patient and physician attitudes. Clin Infect Dis. 2012;55:1659–60. CrossRef
- Fecal therapy to Eliminate Clostridium difficile-Associated Longstanding diarrhea. Nederlands Trial Register. 2008–2012. http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=1177. Accessed 26 Nov 2012.
- Lawley TD, Clare S, et al. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog. 2012;8:e1002995. CrossRef
- van Nood E, Vrieze A, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368:407–415.
- Fecal Bacteriotherapy for Recurrent Clostridium difficile Infection: What’s Old Is New Again?
Current Infectious Disease Reports
Volume 15, Issue 2 , pp 101-103
- Cover Date
- Print ISSN
- Online ISSN
- Current Science Inc.
- Additional Links
- Clostridium difficile infection
- Recurrent Clostridium difficile infection
- Fecal microbiota transplantation
- Fecal bacteriotherapy
- Industry Sectors